US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.45

+0.52160.86%

Post-market: 61.450.00000.00%19:30 EDT

Volume:192.56K

Turnover:11.76M

Market Cap:271.61M

PE:20.10

High:62.12

Open:61.37

Low:60.40

Close:60.93

52wk High:64.10

52wk Low:39.36

Shares:4.42M

Float Shares:4.42M

Volume Ratio:6.46

T/O Rate:4.36%

Dividend:1.53

Dividend Rate:2.48%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Axsome's Auvelity Strength Expected to Drive H2 Revenue Growth, RBC Says

MT Newswires Live

Tango Falls After Wider-than-Expected Quarterly Loss

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)

Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results

Benzinga Earnings

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live

Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%

THOMSON REUTERS

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)

CervoMed Q2 Net Loss Lower than Estimates as Costs Drop

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PTH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":61.45,"timestamp":1788379200000,"preClose":60.9284,"halted":0,"volume":192563,"hourTrading":{"tag":"盘后","latestPrice":61.45,"preClose":61.45,"latestTime":"19:30 EDT","volume":10,"amount":614.5,"timestamp":1788391802992,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008560868166569275,"floatShares":4420000,"shares":4420000,"eps":3.057033,"marketStatus":"Post-Mkt","change":0.5216,"latestTime":"09-02 19:55:08 EDT","open":61.3732,"high":62.12,"low":60.4,"amount":11760338.478839999,"amplitude":0.02823,"askPrice":61.82,"askSize":4900,"bidPrice":60.83,"bidSize":4900,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":60.9284,"sharesOutstanding":2480000,"nav":60.75388,"aum":269747227.2,"dividendRate":0.024845,"bidAskSpread":0.001923,"preHourTrading":{"tag":"盘前","latestPrice":60.9284,"preClose":60.9284,"latestTime":"07:36 EDT","volume":3,"amount":182.7852,"timestamp":1788348989320,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":61.45,"preClose":61.45,"latestTime":"19:30 EDT","volume":10,"amount":614.5,"timestamp":1788391802992,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":6.461672,"impliedVol":0.116,"impliedVolPercentile":0.4405},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4420000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":6.461672,"shares":4420000,"dividePrice":1.5267,"high":62.12,"amplitude":0.02823,"preClose":60.9284,"low":60.4,"week52Low":39.36,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":61.45,"eps":3.057033,"divideRate":0.024845,"volume":192563,"delay":0,"ttmEps":3.057033,"open":61.3732,"prevYearClose":49.701,"prevWeekClose":61.0661,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":63.629,"twentyDayClose":60.0964,"sixtyDayClose":48.9492},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658949165","title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949165?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:23","pubTimestamp":1786487005,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman disposes of $ 10.75 million in common sharesGuardant Health Chief Commercial Officer Chris Freeman exercised stock options for 63,605 shares on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4khYKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GDOC","GNMX","BK4551","LU0109394709.USD","FFOX","LU0889565916.HKD","PTH","EKG","BK4196","BK4588","GNOM","HELX","LU0320765992.SGD","BK4585","GH","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911089","title":"Axsome's Auvelity Strength Expected to Drive H2 Revenue Growth, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911089","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911089?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:51","pubTimestamp":1786463486,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics'  Q2 results showed continued strength from Auvelity, its treatment for major depressive disorder, with the drug's new indication expected to drive revenue growth in H2, RBC Capital Markets said Monday in a report.Auvelity generated $180 million in revenue in the quarter, topping Wall Street's $176 million estimate, \"which may help to drive some incremental upside as investors lift their outlook for the drug,\" the report said.Continued expansion of Auvelity's use in major depressive disorder, including potential benefits from long-term care, should support total revenue of $804 million in 2026, the report said.Auvelity sales may reach $4.3 billion by 2035, with peak sales potentially reaching $5 billion to $6 billion, and the longer-term opportunity is still not fully reflected in Axsome's share price, the report said.RBC lowered its price target on Axsome stock to $297 from $304 and maintained its outperform rating.Price: 220.55, Change: -0.34, Percent Change: -0.1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AXSM","PTH","BK4505","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658115349","title":"Tango Falls After Wider-than-Expected Quarterly Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658115349","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658115349?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:18","pubTimestamp":1786461505,"startTime":"0","endTime":"0","summary":"BUZZ-Tango falls after wider-than-expected quarterly loss** Shares of drug developer Tango TherapeuticsTNGX.Ofall 3.3% to $26.75** Co reportsQ2 lossof 37 cents/share, vs. analysts' average loss estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44814E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IBB","LU2087621335.USD","IDNA","IE0002270589.USD","LU0861579265.USD","LU2324357040.USD","TNGX","IE00BZ1G4Q59.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","BK4585","LU1778281490.HKD","LU0289739699.SGD","BIB","BK4583","BK4139","LU0114720955.EUR","LU1934455277.USD","TBXU","LU0234570918.USD","MEDI","LU2468319806.SGD","GILD","CANC","LU0109394709.USD","IE00B7SZLL34.SGD","LU1674673691.USD","LU0889565916.HKD","BK4532","SG9999015952.SGD","BK4588","LU0320765992.SGD","LU2089984988.USD","PTH","LU0965508806.USD","IE00BJJMRZ35.SGD","IBBQ","RVMD","LU1066053197.SGD","IE00B4R5TH58.HKD","BBH","LU0965509010.AUD","IE00B19Z3581.USD","BMED","LU1934455863.HKD","LU1066051498.USD","LU1674673428.USD","TMED","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658064919","title":"Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658064919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658064919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:00","pubTimestamp":1786460418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardinal Health (CAH), Axsome Therapeutics (AXSM) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0310799852.SGD","LU1880398471.USD","LU0792757196.USD","BK4588","LU1571399168.USD","BK4585","BK4581","LU1983299246.USD","LU2324357040.USD","LU0128525689.USD","XLV","LU0128526141.USD","AXSM","LU1267930813.SGD","LABU","LU0211327993.USD","BK4175","BK4137","LU0052756011.USD","LU0310800965.SGD","LU1267930490.SGD","LU0029874061.USD","CAH","LU1880398554.USD","PTH","LU0072461881.USD","SG9999001440.SGD","BK4139","BK4007","LU0006061336.USD","BBIO","HCSG","LU0162691827.USD","BK4505","LU0211328371.USD","XBI","LU0889566641.SGD","LU0154236417.USD","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919566","title":"Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919566","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919566?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:30","pubTimestamp":1786458628,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (NASDAQ:AXSM) reported Q2 losses of 99 cents per share and sales of $218.4 million, missing analyst estimates. Analysts have mixed price targets for the stock.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61112506/axsome-therapeutics-analysts-increase-their-forecasts-following-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PTH","AXSM","BK4585","LU2324357040.USD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658130309","title":"U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2658130309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658130309?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:21","pubTimestamp":1786454464,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal HealthAugust 11 (Reuters)-Wall Street's main indexes were poised to open higher on Tuesday as investors welcomed a report suggesting the United ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL6N4480DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861220207.SGD","LU1880398554.USD","BK4175","LU2125910500.SGD","AIS","ESPO","LU0109394709.USD","LU2089985449.USD","LU1242518857.USD","BK4212","BK4085","LU2238330802.EUR","SG9999002604.SGD","LU0052756011.USD","LU2065171402.SGD","BK4077","UAA","LU2177674079.SGD","SG9999014484.SGD","IE0001KFT4U8.USD","SG9999002414.USD","LU0516422440.USD","BK4218","IE00B2B36J28.USD","WSPC","CWII","MARS","SG9999001440.SGD","LU1621767737.EUR","LU0472753341.HKD","GAP","LU0175139822.USD","NURE","BK4120","ASTS","BK4503","LU0499858438.USD","BBH","ASTN","BK4181","LU0069063385.USD","LU0154236417.USD","IE00B4R5TH58.HKD","STTK","LU0081259029.USD","BK4225","FXG","LU1861220033.SGD","BK4094","DIPR","VG","LU2362540622.SGD","SG9999002406.SGD","HERO","JAN","CRWU","LU0516423174.USD","NETG","LU2290526834.HKD","LU1621767810.EUR","SG9999002950.SGD","BK4187","SFD","RVMD","LU0289960550.SGD","FUTY","LU0979878070.USD","HIYY","IE000M9KFDE8.USD","LU1861215975.USD","RKLB","CAH","ONON","LU0889566641.SGD","LU2286300806.USD","IE0009355771.USD","LU1880398471.USD","FDNI","BK4116","BK4554","BK4585","LU0264606111.USD","LU1804176565.USD","BK4560","BK4581","LU0589944569.HKD","LU1621768206.USD","LU2265009873.SGD","BK4089","LU2152927971.USD","RKLX","NUKX","LU0511384066.AUD","CORD","BK4196","CLOU","LU2543165471.USD","LU0823038988.USD","BK4146","LU0792757196.USD","FPWR","LU1983299246.USD","LU0719512351.SGD","LU1585245621.USD","WBTN","ACIU","LU0210637038.USD","IE0009354923.USD","LEGN","LU0345776255.USD","LU2362541273.HKD","WARP","BK4213","BK4615","LU0251143029.SGD","LU0348788117.USD","LU2384288077.EUR","CANC","IE00B29SXK94.USD","BSP","IE00BD6J9T35.USD","TRUU","BK4524","HMYY","LU0572939691.SGD","SG9999006266.SGD","THNR","BK4141","LU2362541513.USD","LU1621768115.EUR","LU0345775950.USD","IE0031814969.USD","BK4081","LU0289739343.SGD","IE0002141913.USD","LU1839390173.USD","LU1244550577.SGD","SG9999002679.SGD","LU0057025933.USD","SG9999005177.SGD","LU0128525689.USD","SIMO","BK4548","LU0572940350.SGD","LU0006061336.USD","LU0640476718.USD","LU0082616367.USD","LU0516422952.EUR","XITK","LU0516422366.SGD","XLU","BK4607","LU0889565916.HKD","TTWO","LU1267930227.SGD","DUK","BK4526","BK4139","LU0441851309.USD","AHR","BK4564","LU1244550494.USD","HIMZ","ORBX","BK4202","LU1280957306.USD","LU1861217088.USD","LU2065170008.USD","LU2360107671.USD","MEMS","NET","JXI","LU0072461881.USD","UPW","LU1244550221.USD","HEAL","LU0061475181.USD","LU1323610961.USD","LU0532188223.SGD","LU2008162690.USD","BK4613","BK4023","LU0211328371.USD","LU0274383776.USD","CRWG","LU0737861269.HKD","LU1267930490.SGD","SG9999002620.SGD","SG9999013478.USD","LTL","LU2463526074.USD","LU1242518931.SGD","BK4566","FSPC","LU0048573645.USD","SG9999014492.USD","IE00BJJMRZ35.SGD","LU1571399168.USD","VPU","XLC","LU1267930813.SGD","LU2360107168.USD","BK4547","URAN","IE0034224299.USD","HIMS","PTH","SG9999001135.SGD","LU2125910849.SGD","LU0072462343.USD","LU0320765992.SGD","LU0499858602.USD","LU1861558580.USD","LU0211327993.USD","UFO","SG9999013460.SGD","LU1430594728.SGD","LU0162691827.USD","IDU","RKLZ","XDAT","IE00BJT1NW94.SGD","LU2065169927.USD","SGXZ58947870.SGD","BK4551","BYND","BK4505","IE00BFTCPJ56.SGD","CRWV","GLAM","LU0310799852.SGD","LU0261945553.USD","BK4588","BK4007","WTRE","BK4535","RSPC","RHP","LU2045819591.USD","HIMY","BNGE","LU1770036033.HKD","NETX","SE","SG9999013486.USD","BK4220","SG9999004360.SGD","IE00B29SXL02.USD","BK4606","CWVX","LU1861559042.SGD","IDNA","LU0516423091.SGD","LU2065171311.SGD","LU1048588211.SGD","NERD","LU0289961442.SGD","MEDI","LU0310800965.SGD","LU0823039010.USD","ASTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658528997","title":"Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2658528997","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658528997?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:41","pubTimestamp":1786448509,"startTime":"0","endTime":"0","summary":"BUZZ-Truist raises Revolution Medicines PT on lung cancer pipeline potential** Brokerage Truist Securities raises price target for Revolution MedicinesRVMD.Oto $231 from $210** Maintains \"buy\" rating** Says recent advancement of elironrasib and zoldonrasib into late-stage studies in first-line non-small cell lung cancer  strengthens RVMD's position in RAS-targeted cancers** Sees both programs expanding RVMD's addressable market in lung cancer and supporting a more diversified RAS franchise**The new price target represents a 11.6% upside to the stock's last close** Brokerage continues to expect potential approval ofdaraxonrasibin previously treated pancreatic cancer in Q3 2026** \"While pricing remains an open question, mgmt expressed confidence that organizational, market access, patient-support and distribution capabilities will not be limiting factors\" - Truist says** As of last close, stock has more than doubled YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N4480SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0320765992.SGD","CANC","IDNA","PTH","IE00BJT1NW94.SGD","LU0889565916.HKD","RVMD","IE00BFTCPJ56.SGD","BBH","IE0009355771.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4139","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658925009","title":"Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2658925009","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658925009?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:10","pubTimestamp":1786446639,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals Q2 sales rise on PEDMARK demandOverviewUS specialty pharma's Q2 net product sales rose 78% yr/yr, driven by PEDMARK demandNon-GAAP adjusted EBITDA for Q2 turned positive from a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HRTX","BK4505","FENC","AXSM","BK4585","BK4007","LU2324357040.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123475942","title":"BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1123475942","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123475942?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:46","pubTimestamp":1786412777,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) saw its shares surge more than 4% during early trading hours, before settling at a 2.72% gain to 219 Hong Kong dollars, with a trading volume of 297 million Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","BK4585","BK0239","IE00B2B36J28.USD","BK4588","LU0109394709.USD","ONC","BK1588","LU0228659784.USD","LU2328871848.SGD","BK1500","LU1251922891.USD","BBH","BK1583","BK4139","VXUS","LU0320765992.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE0009354923.USD","LU1719994722.HKD","IDNA","LU0828237510.HKD","LU1969619763.USD","LU1770034418.SGD","LU0307460666.USD","RVMD","IE00B4R5TH58.HKD","KURE","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1303224171.USD","BK4526","BK1161","06160","CANC","PTH","LU0588546209.SGD","IE0002141913.USD","KCAI","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599689","title":"Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599689?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392812,"startTime":"0","endTime":"0","summary":"Guardant Health grants 46,044 RSUs to 149 new employees under inducement planGuardant Health set inducement RSU grants covering 46,044 common shares for 149 new non-executive hires, with an Aug. 3, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL208d3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","HELX","BK4196","BK4535","BK4585","EKG","FFOX","BK4551","GH","LU0109394709.USD","PTH","GNMX","GDOC","LFSC","LU0889565916.HKD","BK4588","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658295379","title":"3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658295379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658295379?lang=en_us&edition=fundamental","pubTime":"2026-08-11 01:44","pubTimestamp":1786383867,"startTime":"0","endTime":"0","summary":"We are diving into three healthcare stocks which all have a Strong Buy consensus and a 10 out of 10 TipRanks Smart Score. The Smart Score is a prop...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-perfect-ten-healthcare-stocks-that-analysts-rate-as-a-strong-buy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-perfect-ten-healthcare-stocks-that-analysts-rate-as-a-strong-buy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","VHT","JHMH","PTH","HCSG","BK4137","XLV","IYH","OEFA","LABU","CURE","IXJ","XLVX","XBI","NOBL","LU0029874061.USD","BK4550","TCAF","BK4581","LU0128526141.USD","DVXV","BGIG","CGCV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658584679","title":"Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658584679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658584679?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:50","pubTimestamp":1786380608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axso...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heron-therapeutics-hrtx-aquestive-therapeutics-aqst-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heron-therapeutics-hrtx-aquestive-therapeutics-aqst-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4585","BK4581","BK4137","LU2324357040.USD","LU0128526141.USD","AQST","HCSG","AXSM","BK4139","BK4588","BK4505","BK4007","HRTX","LABU","XBI","XLV","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658393127","title":"Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658393127","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658393127?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:30","pubTimestamp":1786368646,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryAxsome Therapeutics, Inc.AXSM.OQreported a quarterly adjusted loss of 99 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N447157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","BK4505","PTH","BK4007","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658155931","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2658155931","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658155931?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:18","pubTimestamp":1786367886,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) up 0.5%.Sionna Therapeu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","XLV","BK4588","HCSG","BK4121","ABCL","BK4137","IBB","LU0128526141.USD","BK4139","LABU","BK4007","BK4585","PTH","BK4505","BK4535","LU0029874061.USD","AXSM","LU2324357040.USD","SION","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658293618","title":"Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658293618","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658293618?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:20","pubTimestamp":1786364445,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4505","BK4007","AXSM","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658593507","title":"Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658593507","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658593507?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:08","pubTimestamp":1786363720,"startTime":"0","endTime":"0","summary":"Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlookOverviewUS biotechnology firm's Q2 net revenue rose 1.3% yr/yr to $37.7 mlnCompany withdrew full-year 2026 guidance citi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470CA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PTH","BK4007","LU2324357040.USD","HRTX","BK4505","AXSM","BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658354779","title":"Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658354779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658354779?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:50","pubTimestamp":1786362616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xencor (XNCR), Revolution Medicines (RVMD) and Roiva...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IE0002141913.USD","XNCR","IE0009355771.USD","PTH","IE00BFTCPJ56.SGD","CANC","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE00BJT1NW94.SGD","BK4585","IE0009354923.USD","IE00B4R5TH58.HKD","LU0128526141.USD","RVMD","IE00B2B36J28.USD","BK4137","LABU","BK4588","BK4139","HCSG","BK4581","LU0889565916.HKD","XBI","BBH","LU0109394709.USD","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658443933","title":"CervoMed Q2 Net Loss Lower than Estimates as Costs Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2658443933","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658443933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:38","pubTimestamp":1786361915,"startTime":"0","endTime":"0","summary":"CervoMed Q2 net loss lower than estimates as costs dropOverviewUS biotech developer's Q2 net loss was lower than analyst expectationsCompany completed $20.5 mln equity financings, extending cash runwa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PTH","AXSM","BK4505","CRVO","BK4585","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938415","title":"Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938415","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938415?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:10","pubTimestamp":1786360249,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics Q2 revenue rises on AUVELITY growthOverviewUS biopharmaceutical firm's Q2 revenue grew 46% yr/yr but missed analyst expectationsNet loss for Q2 widened slightly compared to last ye","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N44709M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4007","LU0566484027.USD","BK4505","BK4539","TMCI","ANIP","AXSM","BK4139","LU1559883803.SGD","GYRE","BK4585","LU2324357040.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893819","title":"Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893819?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:08","pubTimestamp":1786360128,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470MO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4505","AXSM","BK4585","LU2324357040.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}